BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11186980)

  • 1. Methodological advances in cardiac 31P-MR spectroscopy.
    von Kienlin M
    MAGMA; 2000 Nov; 11(1-2):36-8. PubMed ID: 11186980
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance imaging and spectroscopy of the heart.
    de Roos A; van der Wall EE
    Curr Opin Cardiol; 1991 Dec; 6(6):946-52. PubMed ID: 10149602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 31P NMR studies of the kinetics and regulation of oxidative phosphorylation in the intact myocardium.
    Uğurbil K; Kingsley-Hickman PB; Sako EY; Zimmer S; Mohanakrishnan P; Robitaille PM; Thoma WJ; Johnson A; Foker JE; From AH
    Ann N Y Acad Sci; 1987; 508():265-86. PubMed ID: 2964217
    [No Abstract]   [Full Text] [Related]  

  • 4. [31P magnetic-resonance spectroscopy in cardiac diseases].
    Mazaev VV; Stukalova OV; Ternovoĭ SK; Chazova IE
    Kardiologiia; 2012; 52(3):67-73. PubMed ID: 22839445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients.
    Chida K; Otani H; Saito H; Nagasaka T; Kagaya Y; Kohzuki M; Zuguchi M; Shirato K
    Acta Radiol; 2005 Jul; 46(4):386-90. PubMed ID: 16134315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the isolated perfused rat heart exposed to ischemia using 31P NMR surface coil.
    Zhang R; Yan Y; Luo X; Wang X; Fan L
    Ann N Y Acad Sci; 2000 May; 904():42-4. PubMed ID: 10865708
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of myocardial viability by 31P-MR-spectroscopy and 23Na-MR imaging.
    Beer M; Sandstede J; Pabst T; Landschütz W; Harre K; von Kienlin M; Voelker W; Neubauer S; Hahn D
    MAGMA; 2000 Nov; 11(1-2):44-6. PubMed ID: 11186983
    [No Abstract]   [Full Text] [Related]  

  • 8. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
    Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M
    Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [31P-cardio-MR-spectroscopy in myocardial insufficiency].
    Krahe T; Schindler R; Neubauer S; Ertl G; Horn M; Lackner K
    Rofo; 1993 Jul; 159(1):64-70. PubMed ID: 8334261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance spectroscopy of the heart.
    Schaefer S; Massie B; Weiner MW
    Cardiol Clin; 1989 Aug; 7(3):697-712. PubMed ID: 2670234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclical changes in high-energy phosphates during the cardiac cycle by pacing-Gated 31P nuclear magnetic resonance.
    Honda H; Tanaka K; Akita N; Haneda T
    Circ J; 2002 Jan; 66(1):80-6. PubMed ID: 11999671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of phosphomonoester signals in proton-decoupled 31P NMR spectra of the myocardium of patients with myocardial hypertrophy.
    Jung WI; Sieverding L; Breuer J; Schmidt O; Widmaier S; Bunse M; van Erckelens F; Apitz J; Dietze GJ; Lutz O
    J Magn Reson; 1998 Jul; 133(1):232-5. PubMed ID: 9654494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of perfluorochemical perfusion in the isolated working rabbit heart preparation using 31P-NMR.
    Freeman D; Mayr H; Schmidt P; Roberts JD; Bing RJ
    Biochim Biophys Acta; 1987 Mar; 927(3):350-8. PubMed ID: 3814627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy.
    Köstler H; Landschütz W; Koeppe S; Seyfarth T; Lipke C; Sandstede J; Spindler M; von Kienlin M; Hahn D; Beer M
    Magn Reson Med; 2006 Oct; 56(4):907-11. PubMed ID: 16964598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function].
    Beer M; Landschütz W; Meininger M; Seyfarth T; Viehrig M; Sandstede J; Pabst T; Kenn W; Horn M; Harre K; von Kienlin M; Neubauer S; Hahn D
    Rofo; 1999 Jul; 171(1):65-8. PubMed ID: 10464508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [31-phosphorus magnetic resonance spectroscopy--a new research instrument in urology. Determination of current status and outlook for clinical use].
    Pomer S
    Urologe A; 1989 Jul; 28(4):223-30. PubMed ID: 2669305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cardiac 31P magnetic resonance spectroscopy at 7 Tesla.
    Rodgers CT; Clarke WT; Snyder C; Vaughan JT; Neubauer S; Robson MD
    Magn Reson Med; 2014 Aug; 72(2):304-15. PubMed ID: 24006267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results].
    Krahe T; Schindler R; Neubauer S; Hillenbrand H; Lackner K; Boesiger P; McKinnon G; Landwehr P; Ertl G
    Rofo; 1991 Dec; 155(6):506-12. PubMed ID: 1764590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A broadband phased-array system for direct phosphorus and sodium metabolic MRI on a clinical scanner.
    Lee RF; Giaquinto R; Constantinides C; Souza S; Weiss RG; Bottomley PA
    Magn Reson Med; 2000 Feb; 43(2):269-77. PubMed ID: 10680691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy.
    Bottomley PA
    Science; 1985 Aug; 229(4715):769-72. PubMed ID: 4023711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.